Alliancebernstein L.P. Atri Cure, Inc. Transaction History
Alliancebernstein L.P.
- $280 Billion
- Q4 2024
A detailed history of Alliancebernstein L.P. transactions in Atri Cure, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 3,835,449 shares of ATRC stock, worth $130 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
3,835,449
Previous 3,972,448
3.45%
Holding current value
$130 Million
Previous $111 Million
5.23%
% of portfolio
0.04%
Previous 0.04%
Shares
24 transactions
Others Institutions Holding ATRC
# of Institutions
229Shares Held
47.1MCall Options Held
25.8KPut Options Held
4.5K-
Vanguard Group Inc Valley Forge, PA4.65MShares$158 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.62MShares$157 Million0.0% of portfolio
-
Hood River Capital Management LLC Palm Beach Gardens, FL2.92MShares$99.2 Million1.54% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT2.53MShares$85.8 Million0.51% of portfolio
-
Macquarie Group LTD Australia, C32.38MShares$80.6 Million0.08% of portfolio
About AtriCure, Inc.
- Ticker ATRC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 46,424,700
- Market Cap $1.58B
- Description
- AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...